The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.
Pemvidutide improves fibrosis markers, liver fat, lipids, weight, and blood pressure in patients with MASH at 1 year, phase 2b data show.
CHICAGO -- RASolute 302 trial results were hailed as a game-changing breakthrough in the treatment of pancreatic cancer. The phase III study showed that second-line daraxonrasib, an investigational ...
Eating too much added sugar may increase liver fat and raise the risk of fatty liver disease. Talk to your healthcare provider about appropriate diet changes.
How animals navigate by Earth's magnetic field is hotly debated. New research in pigeons points to iron-laden liver immune ...
I’m 70 years old, and my whole family is prone to edema, varicose veins and deep vein thrombosis due to venous insufficiency.
Morning Overview on MSN
UT Southwestern just uncovered a hidden 'master switch' that decides how much cholesterol the liver pumps into the bloodstream — and how to turn it off
Every day, your liver assembles billions of tiny cholesterol-carrying particles and ships them into your blood. How many it ...
Air Force officials working on the cleanup of PFAS at the former Wurtsmith Air Force Base in Oscoda have extended the ...
Researchers added paricalcitol to chemotherapy and assessed outcomes in metastatic pancreatic cancer. The treatment remodeled ...
The husband of a woman who overcame breast cancer at 36 has shared how his wife initially believed her symptoms were merely ...
The husband of a woman who was diagnosed with pancreatic cancer at 54 said she thought she just had ‘simple indigestion’ ...
A small clinical trial led by Dana-Farber Cancer Institute researchers put a Salk Institute idea to the test in patients: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results